ImmunityBio, Inc. — Director's Dealing 2018

May 24, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2018-05-21

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-21	Common Stock	S	5557	$3.90	Disposed	418449	Indirect
2018-05-22	Common Stock	S	8546	$3.81	Disposed	409903	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	246280	Direct

Footnotes

F1: Represents closing share price on May 21, 2018.

F2: Represents closing share price on May 22, 2018.